These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2495526)
41. Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease. Cheung MC; Wolfbauer G; Brown BG; Albers JJ Atherosclerosis; 1999 Jan; 142(1):201-5. PubMed ID: 9920522 [TBL] [Abstract][Full Text] [Related]
42. A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. Weisgraber KH; Bersot TP; Mahley RW; Franceschini G; Sirtori CR J Clin Invest; 1980 Nov; 66(5):901-7. PubMed ID: 6776144 [TBL] [Abstract][Full Text] [Related]
43. The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. Curtiss LK; Bonnet DJ; Rye KA Biochemistry; 2000 May; 39(19):5712-21. PubMed ID: 10801321 [TBL] [Abstract][Full Text] [Related]
44. Subfractionation and characterization of native and incubation enlarged human plasma high density lipoprotein particles by high performance gel filtration. Holmquist L; Carlson LA Lipids; 1985 Jun; 20(6):378-88. PubMed ID: 3927099 [TBL] [Abstract][Full Text] [Related]
45. The distribution of cholesterol and apoprotein A-I between the lipoproteins in plasma and peripheral lymph from normal human subjects. Rudra DN; Myant NB; Pflug JJ; Reichl D Atherosclerosis; 1984 Dec; 53(3):297-308. PubMed ID: 6442154 [TBL] [Abstract][Full Text] [Related]
46. Isolation and characterization of apolipoproteins A-I, A-II, and A-IV. Brewer HB; Ronan R; Meng M; Bishop C Methods Enzymol; 1986; 128():223-46. PubMed ID: 3088390 [TBL] [Abstract][Full Text] [Related]
47. Quantification of human serum apolipoprotein A-I by zone immunoelectrophoresis assay and a procedure for the preparation of an A-I standard. Holmquist L; Vesterberg O Clin Chim Acta; 1986 Apr; 156(2):131-43. PubMed ID: 3085986 [TBL] [Abstract][Full Text] [Related]
48. Mechanism of action of gemfibrozil on lipoprotein metabolism. Saku K; Gartside PS; Hynd BA; Kashyap ML J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042 [TBL] [Abstract][Full Text] [Related]
49. Characterization of baboon plasma high-density lipoproteins and of their major apoproteins. Blaton V; Vercaemst R; Rosseneu M; Mortelmans J; Jackson RL; Gotto AM; Peeters H Biochemistry; 1977 May; 16(10):2157-63. PubMed ID: 193555 [TBL] [Abstract][Full Text] [Related]
50. Immunochemical characterization of apolipoprotein A-I from normal human plasma. In vitro modification of apo A-I antigens. Milthorp P; Weech PK; Milne RW; Marcel YL Arteriosclerosis; 1986; 6(3):285-96. PubMed ID: 3085646 [TBL] [Abstract][Full Text] [Related]
51. Isolation of a helical, lipid-binding fragment from the human plasma high density lipoprotein, apoLP GLN-I. Jackson RL; Baker HN; David JS; Gotto AM Biochem Biophys Res Commun; 1972 Dec; 49(6):1444-51. PubMed ID: 4344811 [No Abstract] [Full Text] [Related]
52. High-density lipoprotein and its apolipoproteins inhibit cytolytic activity of complement. Studies on the nature of inhibitory moiety. Packman CH; Rosenfeld SI; Leddy JP Biochim Biophys Acta; 1985 Jan; 812(1):107-15. PubMed ID: 3917679 [TBL] [Abstract][Full Text] [Related]
53. An alternate apoprotein conformation in high density apolipoprotein discoidal complexes. A Fourier transform infra-red study. Yang JY; Treleaven WD; Cushley RJ Biochem Int; 1991 Dec; 25(6):1077-86. PubMed ID: 1810252 [TBL] [Abstract][Full Text] [Related]
54. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. Chajek-Shaul T; Hayek T; Walsh A; Breslow JL Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6731-5. PubMed ID: 1907375 [TBL] [Abstract][Full Text] [Related]
55. Contribution of alpha helix formation in human plasma apolipoproteins to their enthalpy of association with phospholipids. Massey JB; Gotto AM; pownall HJ J Biol Chem; 1979 Oct; 254(19):9559-61. PubMed ID: 226521 [TBL] [Abstract][Full Text] [Related]
56. Functional similarities of human and chicken apolipoprotein A-I: dependence on secondary and tertiary rather than primary structure. Kiss RS; Ryan RO; Francis GA Biochim Biophys Acta; 2001 Apr; 1531(3):251-9. PubMed ID: 11325616 [TBL] [Abstract][Full Text] [Related]
57. The influence of lipid on the conformation of human plasma high density apolipoproteins. Lux SE; Hirz R; Shrager RI; Gotto AM J Biol Chem; 1972 Apr; 247(8):2598-606. PubMed ID: 4336379 [No Abstract] [Full Text] [Related]
58. Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits. Ying H; Saku K; Harada R; Takami N; Sasaki N; Saito Y; Arakawa K Biochim Biophys Acta; 1990 Dec; 1047(3):247-54. PubMed ID: 2123720 [TBL] [Abstract][Full Text] [Related]
59. Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. James RW; Hochstrasser D; Tissot JD; Funk M; Appel R; Barja F; Pellegrini C; Muller AF; Pometta D J Lipid Res; 1988 Dec; 29(12):1557-71. PubMed ID: 3149664 [TBL] [Abstract][Full Text] [Related]
60. The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement. Choi-Miura NH; Sakamoto T; Tobe T; Nakano Y; Tomita M J Biochem; 1993 Apr; 113(4):484-7. PubMed ID: 8514737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]